We have previously demonstrated that the fatty acid metabolic enzyme, long chain fatty acyl-CoA synthetase 4 (ACSL4) is differentially expressed in human breast cancer samples as a function of expression of ER and AR [7]. The gene discussed is ACSL4; the disease is breast cancer.